Iver Heron

Title: Iver Heron: Innovator in Immunogenic Conjugates

Introduction

Iver Heron is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of immunology, particularly through his innovative work on immunogenic conjugates. With a total of 2 patents, Heron has demonstrated his expertise and commitment to advancing medical science.

Latest Patents

Heron's latest patents include groundbreaking work on immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide. The first patent discloses a type b polysaccharide-meningococcal outer membrane protein conjugate, along with pharmaceutical compositions designed to induce an immune response in animals. The second patent reiterates this innovative approach, emphasizing the conjugate's potential in enhancing immune responses.

Career Highlights

Iver Heron is currently associated with Baxter International Inc., a leading company in the healthcare sector. His work at Baxter has allowed him to focus on developing novel therapeutic solutions that address critical health challenges.

Collaborations

Some of his notable coworkers include Milan S Blake and Francis Michon. Their collaborative efforts contribute to the innovative environment at Baxter, fostering advancements in immunological research.

Conclusion

Iver Heron's contributions to the field of immunology through his patents and work at Baxter International Inc. highlight his role as a key innovator. His research on immunogenic conjugates is paving the way for new therapeutic strategies in combating infectious diseases.